HyperCVAD regimen

{
  "id": "MLC-T-ONC-014272",
  "term": "HyperCVAD regimen",
  "field": "Oncology and biomedicine",
  "definition": "A regimen consisting of cyclophosphamide, vincristine, doxorubicin and dexamethasone, administered on a hyperfractionated schedule that is used to treat adult acute lymphoblastic leukemia (ALL) or Burkitt-type ALL and adult small non-cleaved cell (Burkitt) lymphoma, AIDS-related B-cell lymphomas, blastic plasmacytoid dendritic cell neoplasm (BPDCN) and T-cell lymphomas.",
  "abbreviation": "HyperCVAD",
  "synonyms": [
    "hyperfractionated cyclophosphamide-vincristine-adriamycin-dexamethasone regimen",
    "Hyper-CVAD regimen"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/hypercvad-regimen/"
}